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The 22q11 region is involved in chromosomal rearrangements that lead to altered gene dosage, resulting in genomic
disorders that are characterized by mental retardation and/or congenital malformations. Three such disorders—
cat-eye syndrome (CES), der(22) syndrome, and velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS)—are
associated with four, three, and one dose, respectively, of parts of 22q11. The critical region for CES lies centromeric
to the deletion region of VCFS/DGS, although, in some cases, the extra material in CES extends across the VCFS/
DGS region. The der(22) syndrome region overlaps both the CES region and the VCFS/DGS region. Molecular
approaches have revealed a set of common chromosome breakpoints that are shared between the three disorders,
implicating specific mechanisms that cause these rearrangements. Most VCFS/DGS and CES rearrangements are
likely to occur by homologous recombination events between blocks of low-copy repeats (e.g., LCR22), whereas
nonhomologous recombination mechanisms lead to the constitutional t(11;22) translocation. Meiotic nondisjunction
events in carriers of the t(11;22) translocation can then lead to offspring with der(22) syndrome. The molecular
basis of the clinical phenotype of these genomic disorders has also begun to be addressed. Analysis of both the
genomic sequence for the 22q11 interval and the orthologous regions in the mouse has identified 124 genes that
are shared between VCFS/DGS and der(22) syndrome and has identified 14 putative genes that are shared between
CES and der(22) syndrome. The ability to manipulate the mouse genome aids in the identification of candidate
genes in these three syndromes. Research on genomic disorders on 22q11 will continue to expand our knowledge
of the mechanisms of chromosomal rearrangements and the molecular basis of their phenotypic consequences.
Introduction
The term “genomic disorders” refers to those diseases
that are caused by chromosomal rearrangements in-
volving large regions of one to several megabase pairs
(reviewed in Lupski 1998). Chromosomal rearrange-
ments can result in interstitial or terminal deletions or
duplications, as well as unbalanced translocations, and
all of these consequences may subsequently result in im-
balanced gene dosage. Meiotic nondisjunction events in
normal carriers of balanced translocations may also lead
to a disturbance of gene dosage in offspring. Each of
these rearrangements occurs sporadically in the popu-
lation and therefore represents the product of de novo
mutations. Many of the rearrangements occur in specific
regions of the genome, suggesting specific mechanisms.
Although each individual disorder is rare in the popu-
lation, when combined, they are responsible for a sub-
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stantial proportion (0.7% of live births) of birth defects
(Borgaonkar 1989). Most of the rearrangements are as-
sociated with both congenital malformations and mental
retardation. Therefore, genomic disorders have a large
impact on human health. The 22q11 region serves as a
model for genomic disorders because it is particularly
susceptible to chromosomal rearrangements, leading to
three different congenital malformation syndromes. In
the present review, we focus on efforts to determine both
the mechanism for the rearrangements and the molecular
basis of these disorders.
Clinical and Cytogenetic Features of Genomic
Disorders on 22q11
The most common genomic disorder on 22q11 is ve-
locardiofacial syndrome/DiGeorge syndrome (VCFS/DGS
[MIM 192430; MIM 601362]). With a frequency of 1/
4,000 live births (Burn and Goodship 1996), VCFS/DGS
is the most common genomic disorder in humans. The
main clinical findings include learning disabilities, char-
acteristic facial appearance, velopharyngeal insufficiency,
hypernasal speech, occult cleft palate, and conotruncal
heart defects (outflow-tract defects) (Shprintzen et al.
1978). A more severely affected subset of patients have
a reduced or absent thymus gland and hypocalcemia (Di-
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George 1965). There are many additional clinical findings
that are associated with this disorder. Most features show
variable expressivity and penetrance. In addition to hav-
ing physical malformations, most affected children have
learning disabilities and behavioral disorders (Swillen et
al. 1999). Adults with this syndrome develop major psy-
chiatric illnesses, including schizophrenia and bipolar dis-
order (Chow et al. 1994; Pulver et al. 1994; Papolos et
al. 1996; Murphy et al. 1999; Shprintzen 2001; reviewed
in Murphy and Owen 2001). Most patients with VCFS/
DGS have a deletion in 22q11, making this region hem-
izygous (fig. 1) (de la Chapelle et al. 1981; Driscoll et al.
1992; Scambler et al. 1992; Lindsay et al. 1993). The
deletion was first identified by cytogenetic methods and
was later confirmed by molecular approaches, including
FISH (Driscoll et al. 1993) and haplotype analysis with
genetic markers (Morrow et al. 1995).
In contrast to VCFS/DGS, cat-eye syndrome (CES
[MIM 115470]) and der(22) syndrome are rare dis-
orders. The clinical findings for CES are distinct from
those in patients with VCFS/DGS, and features of CES
include ocular colobomata, anal atresia, congenital
heart defects (typically, total anomalous pulmonary ve-
nous return [TAPVR]), renal malformations, craniofa-
cial anomalies (e.g., preauricular skin tags and pits),
male genital anomalies, skeletal defects, and border-
line-to-moderate mental retardation (Schinzel et al.
1981; reviewed in Berends et al. 2001). As with VCFS/
DGS, most features show variable expressivity and pen-
etrance. Patients with CES have a partial tetrasomy
(i.e., four copies) of the region that spans the p-arm
and part of 22q11 (fig. 1) (Schinzel et al. 1981;
McDermid et al. 1986). The extra copies of this region
are usually in the form of a chromosome that is su-
pernumerary, bisatellited, and dicentric—that is, an inv
dup(22), or the CES chromosome. Features of CES (in-
cluding colobomata and TAPVR) have also been as-
sociated with interstitial duplications (i.e., three copies)
of part of the 22q11 region (Reiss et al. 1985; Knoll
et al. 1995).
The second disorder associated with increased gene
dosage of 22q11 is der(22) syndrome. Many of the
clinical findings for der(22) syndrome are the same as
those for CES, although there are also distinct differ-
ences (Fraccaro et al. 1980; Van Hove et al. 1992).
Features of der(22) syndrome that are similar to CES
include heart defects (primarily, atrial septal defects;
conotruncal heart defects are not a finding in this syn-
drome; Lin et al. 1986), renal malformations, craniofa-
cial anomalies (e.g., preauricular tags and pits and cleft
palate), male genital anomalies, anal stenosis or atresia,
skeletal defects, and mental retardation (reviewed in
Knoll et al. 1995). Interestingly, colobomata, micro-
phthalmia, and TAPVR, which are common in CES,
are not seen in these patients. Der(22) syndrome occurs
by nondisjunction events from normal carriers of the
constitutional t(11;22) translocation (fig. 1) (Zakai and
Emanuel 1980). This is the only known constitutional
germline translocation that recurs in humans. Patients
with der(22) syndrome have a partial trisomy of both
the 11q23-qter region and the 22q11-qter region
(Zakai and Emanuel 1980; Schinzel et al. 1981).
Definition of the Regions Harboring Chromosomal
Breakpoints
Definition of the intervals that are rearranged in ge-
nomic disorders on 22q11 has led to insight into the over-
lap between the syndromes, as well as into how the re-
arrangements occur. High-density genetic markers were
used to define the extent of the deletion in patients with
VCFS/DGS. As many as 15 consecutive genetic markers
in the 22q11 region were used to genotype 1150 patients
and their unaffected parents (Carlson et al. 1997). Hap-
lotypes were then deduced on the basis of the genotypes.
Of the 83% of patients with a detectable deletion, 90%
had a similar 3-Mb deletion. Another 7% of deleted pa-
tients had the same proximal breakpoint as those with
the 3-Mb deletion but had a nested distal deletion end-
point resulting in a 1.5-Mb deletion (fig. 2) (Carlson et
al. 1997). Also, there was no sex-based bias (in terms of
whether the deletions occurred on the maternal or pater-
nal chromosome), indicating a lack of imprinting in the
region (Morrow et al. 1995). Deletions of other sizes have
also been identified in the interval, in a small subset of
patients (Edelmann et al. 1999b; Shaikh et al. 2000).
A combination of FISH and quantitative dosage anal-
ysis identified two recurrent regions for the CES break-
points (fig. 2) (Mears et al. 1994; McTaggart et al. 1998).
Each inv dup(22) CES chromosome contains two 22q11
breakpoints (fig. 1), but the location of the individual
breakpoints can differ, thereby resulting in CES chro-
mosomes with duplications of different sizes. The two
recurrent CES breakpoint regions occur in the same in-
tervals as do the proximal and distal breakpoints of the
3-Mb VCFS/DGS deletion (McTaggart et al. 1998; Edel-
mann et al. 1999b). Thus, type I CES chromosomes are
symmetrical, with two proximal breakpoints (fig. 2).
Type II CES chromosomes contain either one proximal
and one distal breakpoint (type IIa, asymmetrical) or
two distal breakpoints (type IIb, symmetrical), resulting
in an additional one or two copies of the VCFS/DGS
region. There is no obvious difference between the phe-
notypes of individuals with type I or type II CES chro-
mosomes, although the syndrome is highly variable and
although relatively few patients have been studied
(McTaggart et al. 1998). That the CES critical region is
centromeric to the 3-Mb region that is deleted in VCFS/
DGS suggests that duplication of the 3-Mb VCFS/DGS
region alone would have a subtle phenotype.
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Figure 1 Rearrangements on 22q11. A multitude of germline rearrangements on 22q11 (boxed) are associated with congenital anomaly
disorders. VCFS/DGS is associated with interstitial hemizygous deletions; a family has been reported with an interstitial duplication of the same
interval that is deleted in patients with VCFS/DGS (Edelmann et al. 1999b). Der(22) syndrome occurs in offspring of unaffected carriers of the
constitutional t(11;22) translocation; patients with der(22) syndrome have a partial trisomy for 22pter-q11 and 11q23-qter. Patients with CES
harbor a bisatellited supernumerary chromosome 22 that results in a partial tetrasomy.
For der(22) syndrome, the t(11;22) breakpoint occurs
in the same interval as does the nested distal 1.5-Mb
VCFS/DGS breakpoint (fig. 2) (Funke et al. 1999; Shaikh
et al. 1999). Thus, this syndrome overlaps the regions
for both CES and VCFS/DGS, suggesting that 22q11 is
exquisitely prone to a multitude of rearrangements.
Together, the coincident locations of the breakpoints
in most patients with the three genomic disorders on
22q11 that we herein review provide strong evidence for
site-specific mechanisms for the sporadic rearrangements
on 22q11. This evidence was further elucidated using
BAC and cosmid libraries to generate physical maps of
22q11 (Collins et al. 1995). Analysis of the breakpoint
regions demonstrated that sequences that are present in
the common 3-Mb proximal breakpoint interval were
repeated in the 1.5- and 3-Mb distal breakpoint intervals
(e.g., LCR22; see fig. 2) (Edelmann et al. 1999a; Shaikh
2000), suggesting that recombination between the in-
tervals results in the chromosomal rearrangements.
Mechanisms for Rearrangements on 22q11
All three breakpoint regions, each of which are 1.5
Mb apart, harbor a similar low-copy repeat (LCR) that
is known as an “LCR22” (fig. 2) (Edelmann et al.
1999a). Each LCR22 is larger than the inserts in the
genomic clones that were used to construct the map.
Therefore, the strategy to isolate overlapping clones
that span each LCR22 was to identify distinguishing
characteristics in each. Unique PCR-based landmarks
that flanked each LCR22 were used to anchor genomic
clones to individual LCR22s (Edelmann et al. 1999a).
Clones that spanned the LCR22s have been sequenced
and analyzed (Dunham et al. 1999). The two LCR22s
that are 3 Mb apart are ∼200 kb and contain direct
and inverted segments or modules (Dunham et al.
1999; Bailey et al. 2002). These regions contain genes,
pseudogenes, and other genomic sequences that are
94%–99% identical within each component—both in
and between each LCR22. The central LCR22, LCR22-
3a (fig. 2) contains a gap in the physical map that has
not been fully cloned, despite efforts to do so.
Therefore, these three LCR22s are present in the
regions of chromosome breakage in three different
genomic disorders. The VCFS/DGS common proximal
endpoint and the CES type I endpoint map to LCR22-
2, whereas the 3-Mb distal deletion endpoint in pa-
tients with VCFS/DGS and the CES type II endpoint
map to LCR22-4. The 1.5-Mb distal deletion end-
point in patients with VCFS/DGS and the t(11;22)
breakpoint map to LCR22-3a (fig. 2) (Funke et al.
1999). We also predict that there are CES chromo-
somes with one or both breakpoints at the central
LCR22-3a. A probable example was described by
Crolla et al. (1997), in which a supernumerary inv
dic(22) in a child and her father was shown by FISH
to contain the HIRA gene (between LCR22-2 and
LCR22-3a) but not the genetic marker D22S264 (be-
tween LCR22-3a and LCR22-4). That the child dis-
played only developmental delay, severe hypotonia,
and seizures and that the father was unaffected in-
dicate the wide phenotypic variation seen for partial
tetrasomy of 22q11.
Homologous recombination events between the
LCR22s during meiosis have been implicated in VCFS/
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Figure 2 LCR22s in mediation of chromosomal rearrangements. LCR22 designations have been described elsewhere (Dunham et al.
1999). The proximal endpoints for the 1.5- and 3-Mb VCFS/DGS deletions occur in LCR22-2, and the distal endpoints occur in LCR22-3a
and LCR22-4, respectively. The constitutional t(11;22) translocation disrupts LCR22-3a. Three CES-duplication endpoints—those for types I,
IIa, and IIb—are shown. Deletions (white boxes), partial trisomies (i.e., three copies; gray boxes), and partial tetrasomies (i.e., four copies;
black boxes) are depicted.
DGS and CES rearrangements on the basis of hap-
lotype analysis of three generations of individuals
with VCFS/DGS (Baumer et al. 1998; Edelmann et al.
1999b; reviewed in Emanuel and Shaikh 2001). The
reason for such a multitude of rearrangements lies in
the complicated inverted and direct orientation of se-
quences in the LCR22s. For VCFS/DGS, both intrachro-
mosomal and interchromosomal mechanisms occur
(Baumer et al. 1998; Edelmann et al. 1999b). Ho-
mologous recombination between inverted and direct
repeats in LCRs of sister chromatids and homologous
chromosomes could also lead to U-type exchange
(rather than the classic crossover X-type exchange),
which would result in the formation of the inv dic(22)
of CES, as well as an acentric fragment that would
be lost (Schreck et al. 1977; Van Dyke et al. 1977).
Der(22) syndrome occurs in offspring of carriers of
the constitutional t(11;22) translocation. The balanced
t(11;22) translocation, although a rare event, is recurrent
in the population (Zackai and Emanuel 1980). The in-
tervals on 22q11 (Funke et al. 1999) and 11q23 (Edel-
mann et al. 1999c) that contain the region of chro-
mosome breakage have been mapped and cloned
(Kurahashi et al. 2000a, 2000b; Edelmann et al. 2001).
The sites of chromosome breakage on 11q23 and 22q11
occur in AT-rich palindromic sequences. Such sequences
are known to be unstable in eukaryotic genomes. The
sites of chromosome breakage occur in the center of the
palindromes of both parental chromosomes 11q23 and
22q11 (Edelmann et al. 2001; Kurahashi and Emanuel
2001). We hypothesize that double-strand breaks at the
tip of a putative hairpin, the center of the palindrome,
lead to nonhomologous end-joining mechanisms that re-
sult in the formation of a stable, nonpalindromic se-
quence. Such rearrangements have been described in
mammalian cell-culture systems (Akgun et al. 1997).
Since interchromosomal recombination events occur
sporadically in the population, individuals that carry a
reciprocal duplication of the same region that is deleted
in VCFS/DGS should exist, if the condition is not lethal.
This region’s presence in one or two extra copies in some
cases of CES without obvious additional clinical features
indicates that the phenotype of the VCFS/DGS-region
duplication alone would likely show subtle or no effect.
One such family was identified, in which the proband,
her mother, and her grandmother carried a VCFS/DGS-
region duplication (fig. 1) (Edelmann et al. 1999b). The
proband was mildly affected, with developmental delay
and hypotonia, but the mother and grandmother ap-
peared to be unaffected (Edelmann et al. 1999b). Be-
cause of the mild nature of the anomalies and the dif-
ficulty of detecting submicroscopic duplications, it is
likely that there are many individuals in the population
with a similar rearrangement but that they remain un-
diagnosed. This would represent a fourth genomic dis-
order on 22q11.
Both homologous and nonhomologous recombina-
tion mechanisms that involve LCR22s lead to germline
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rearrangements on 22q11. Therefore, the genomic dis-
orders on the 22q11 region serve as models to under-
stand the molecular basis of chromosomal rearrange-
ments in humans.
Animal Models for Genomic Disorders on 22q11
Since genomic disorders on 22q11 involve large regions
of the genome, it is possible that the altered dosage of
several contiguous genes is responsible for their etiology.
Alternatively, only a single gene may be responsible. To
determine the molecular basis of genomic disorders, it is
possible to take mouse-genetics approaches. The gener-
ation of the complete sequence of chromosome 22 (Dun-
ham et al. 1999) and orthologous regions in the mouse
have provided the tools for such efforts (Dunham et al.
1999; Lund et al. 1999).
Although candidate genes can be chosen for study on
the basis of both their presence in a critical region and
their expression patterns, ultimate proof of their involve-
ment in a genomic disorder can be difficult. The dis-
covery of patients who harbor balanced translocations
in 22q11 and have VCFS/DGS-related malformations
was a disappointment, because there were no obvious
candidates that were interrupted (Budarf et al. 1995;
Levy et al. 1995; Sutherland et al. 1996; Holmes et al.
1997), thereby implying that the translocations created
positional effects on neighboring genes. Another more
successful strategy is the generation of mouse models
that contain large nested deletions or duplications (Ra-
mirez-Solis et al. 1995; Zheng et al. 2000; reviewed in
Yu and Bradley 2001) This is possible as long as the
genes of the human critical region are conserved as a
unit on an individual mouse chromosome. Once the crit-
ical region for the syndrome is narrowed in the mouse
model that harbors large rearrangements, each individ-
ual gene within the region can be inactivated using con-
ventional gene-targeting approaches. The gene-targeted
mutants can be compared with those mice that harbor
chromosomal rearrangements to ascertain whether the
disorder is a single or contiguous gene syndrome.
The 1.5-Mb region shared between VCFS/DGS and
der(22) syndrome (and sometimes duplicated or tripli-
cated in CES) lies on mouse chromosome 16 (MMU16)
(Puech et al. 1997; Lund et al. 1999). It was possible to
generate nested deletions within chromosome 16 to gen-
erate mouse models of VCFS/DGS (see below), since pa-
tients with VCFS/DGS who have the 1.5-Mb deletion
have the same phenotypic spectrum as patients with the
larger, 3-Mb deletion (Morrow et al. 1995). The distal
1.5-Mb VCFS/DGS region lies on mouse chromosome
10 (MMU10; see Human-Mouse Homology Map). For
confirmation that altered dosage of this region does not
affect the overall phenotype of VCFS/DGS, a deletion
of this interval on MMU10 could also be generated.
Making CES mouse models may be more problematic.
Most of the CES critical region (from IL-17R to ATP6E
and MIL1; see fig. 3) maps to mouse chromosome 6
(MMU6; see Human-Mouse Homology Map) (Puech et
al. 1997; Footz et al. 1998). Although a duplication of
this region could be created, one of the human candidate
genes (CECR1; see next section) is missing from this
region of MMU6 and probably does not exist in the
mouse genome (Footz et al. 2001). In addition, the CES
critical region includes the 22q11 pericentromeric DNA,
which contains a primate-specific patchwork of frag-
ments that are duplicated from other human chromo-
somes (Footz et al. 2001; Bailey et al. 2002). Although
this region is unlikely to contain active genes, any that
do exist would not be present in the mouse.
Tbx1 as a Candidate Gene for VCFS/DGS in Mouse
Models
Many of the tissues and structures affected in patients
with VCFS/DGS derive, during embryonic development,
from the pharyngeal arches (reviewed in Kirby and
Waldo 1995), which are conserved among all vertebrate
organisms. Neural-crest cells migrate from a position
adjacent to the neural tube and participate in the for-
mation of both the pharyngeal arches and their deriv-
atives. It has been hypothesized that defects in neural-
crest cells are responsible for the characteristic features
of VCFS/DGS (Kirby et al. 1983, 1985; Bockman and
Kirby 1984; Phillips et al. 1987; Couly and Le Douarin
1987; reviewed in Kirby and Waldo 1995). Neural-crest
ablation generates mice with malformations that are
similar to those in patients with VCFS/DGS (Kirby et al.
1983; Bockman and Kirby 1984; Bockman et al. 1987).
Therefore, a gene that is important for neural-crest cell
function would be a candidate for VCFS/DGS.
For the identification of candidates for VCFS/DGS,
nested deletions and duplications of the orthologous re-
gion on MMU16 were generated (fig. 3) (Puech et al.
1997; Kimber et al. 1999; Lindsay et al. 1999, 2001;
Merscher et al. 2001). Mice that harbor a large, 1.5-Mb
deletion (fig. 3), containing 124 genes and mimicking
the nested 1.5-Mb deletion in humans, had reduced vi-
ability, conotruncal heart defects, and hypoparathyroid-
ism. A critical region for these cardiovascular defects
was defined through genetic complementation between
different-sized deletions and BAC-containing transgenic
mice (fig. 3) (Lindsay et al. 2001; Merscher et al. 2001).
A BAC that harbored four human genes—GP1Bb,
PNUTL1, TBX1, and WDR14—provided complete res-
cue in most mice (Merscher et al. 2001). A PAC that
contained the mouse homologues of the four genes pro-
vided complete rescue of the cardiovascular findings in
embryos (Lindsay et al. 2001), suggesting that one of
these four genes is responsible for the defects. It was
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Figure 3 Map of human 22q11 region and orthologous regions in mouse. The relative order of genes (circles) on the 22q11 region
(HSA22) and orthologous genes on MMU6 (for CES) and MMU16 (for VCFS/DGS) are shown. The arrows between the human and mouse
maps indicate orientation. Deletions that have been generated in MMU16, to generate mouse models of VCFS/DGS, are indicated by a solid
blue line below MMU16. BAC transgenic lines that harbor human genes in the distal half of the 1.5-Mb region that is deleted in patients with
VCFS/DGS have also been generated, to overexpress sets of genes for genetic complementation studies; the genes included in these lines are
indicated at the bottom of the figure.
noteworthy that the human transgene could not provide
complete rescue, although this may have been due to
either the insufficient expression of the transgenes or the
inability of the human genes to completely replace the
endogenous mouse genes.
One of the four genes in the BAC—TBX1, a member
of the T-box–containing family of transcription-factor
genes—is highly expressed in the pharyngeal arches dur-
ing mouse embryonic development (Chapman et al.
1996). This gene was targeted for inactivation by three
independent research groups (Jerome and Papaioannou
2001; Lindsay et al. 2001; Merscher et al. 2001). Tbx1
hemizygotes had mild cardiovascular defects (Jerome
and Papaioannou 2001; Lindsay et al. 2001; Merscher
et al. 2001) but did not show reduced viability, whereas
homozygotes had more severe defects (Jerome and Pa-
paioannou 2001). Tbx1 homozygosity was perinatally
lethal, with thymus and parathyroid gland aplasia and
major ear malformations. Homozygotes also showed cleft
palate and truncus arteriosus, a more severe conotruncal
heart defect than that shown in the heterozygotes (Jerome
and Papaoiannou 2001). Many of these anomalies occur
in patients with VCFS/DGS but are milder. On the basis
of the three studies, Tbx1 is responsible for VCFS/DGS-
related malformations in mouse models.
Overexpression of Tbx1 may also shed light on other
genomic syndromes on 22q11. BAC-containing trans-
genic mice with overexpression of the four human genes
that are listed above had a similar VCFS/DGS phenotype
of their own. This phenotype included cleft palate, cono-
truncal heart defects, thymus gland hypoplasia, and ear
defects (including chronic otitis media, a common find-
ing in VCFS/DGS), indicating that one of these four
genes is dosage sensitive for this aspect of development
(Funke et al. 2001; Merscher et al. 2001). These results
for the transgenic mouse support the proposal that one
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of the four genes on the human BAC is dosage sensitive
for the development of relevant structures and is there-
fore a candidate gene for VCFS/DGS. It is also possible
that overexpression of one of these genes may contribute
to the overall phenotype in der(22) syndrome or in some
cases of CES.
Other genes in the interval have been considered can-
didate genes for VCFS/DGS. They includeHIRA (similar
to yeast Hir1p and Hir2p) (Lamour et al. 1995; Roberts
et al. 1997, 2002), UFD1L (Pizzuti et al. 1997; Yama-
gishi et al. 1999), and goosecoid-like (GSCL) (Lindsay
et al. 1998; Saint-Jore et al. 1998; Wakamiya et al.
1998), but each has waned from interest because they
did not fulfill the criteria for a candidate gene—that is,
the gene was not expressed in the precursors or the af-
fected structures (GSCL) or neither heterozygotes nor
homozygotes had a relevant phenotype (HIRA, UFD1L,
and GSCL). Another candidate gene of interest is the
CRKL gene, a member of the family of protein-tyrosine
kinases with SH2 and SH3 (src-homology) domains,
which maps to the 22q11 region. Although heterozy-
gotes are normal, mice that harbor null mutations of
Crkl have craniofacial anomalies, outflow-tract heart de-
fects, abnormal thymus and parathyroid glands, and ab-
normalities in the cranial nerves (Guris et al. 2001). The
CRKL gene maps in the 3-Mb deleted interval, which
is distal to the 1.5-Mb region of overlap between the
three disorders. Therefore, it is unlikely that this gene
provides a major contribution to VCFS/DGS. On the
other hand, the deletion or mutation of this gene may
contribute to the overall phenotype in some patients. It
addition, CRKL may be responsible for the defects in
rare patients with deletions that are distal to the 1.5-
Mb region on 22q11 who have congenital anomalies
that are distinct but related to those in patients with
VCFS/DGS (Kurahashi et al. 1996; O’Donnell et al.
1997; Amati et al. 1999; McQuade et al. 1999; Rauch
et al. 1999).
Candidate Genes for Overexpression Genomic
Syndromes on 22q11
The CES critical region was narrowed to the most
proximal 2–2.5 Mb of 22q11 by characterization of an
unusual supernumerary r(22) chromosome in a child
with all the features typical of CES (Mears et al. 1995).
Fourteen genes have been identified in this region, two
of which are present in the pericentromeric repeats and
therefore may be aberrant transcripts without function
(fig. 3) (Footz et al. 2001). Of the remaining 12 tran-
scripts, 2 genes stand out as excellent candidates for
involvement in the duplication phenotype, on the basis
of their putative functions. One of the genes, CECR1,
encodes a homologue of a family of secreted growth
factors that are best characterized in invertebrates (fig.
3) (Riazi et al. 2000). The presence of an adenosine
deaminase (ADA) domain in these family members sug-
gests that these genes function by regulating the con-
centration of extracellular adenosine. Several insect
homologues have been shown to have ADA activity (Li
and Aksoy 2000; Charlab et al. 2001; Zurovec et al.,
in press). In a 35-d human embryo, CECR1 was ex-
pressed in the outflow tract and atrium of the heart and
in the VII/VIII cranial nerve ganglion, suggesting poten-
tial involvement in CES heart and facial defects (Riazi
et al. 2000). A second gene, CECR2, encodes a putative
transcriptional coactivator, which may be sensitive to
dosage changes (Footz et al. 1998; G. S. Banting, un-
published data).
Der(22) syndrome and CES share a similar region of
extra dosage on 22q11. CES is usually associated with
four copies of this region; however, patients with inter-
stitial duplications who have features of CES have been
reported (Reiss et al. 1985; Knoll et al. 1995), which
suggests that CES candidate genes are relevant to der(22)
syndrome. Although the phenotype of der(22) syndrome
shows many similarities to that of CES, it also shows
some significant differences. For instance, mental retar-
dation, cleft palate, and hypotonia are all much more
common in der(22) syndrome than in CES (Fraccaro et
al. 1980; Berends et al. 2001). This presumably results
from the additional presence of three copies of 11q23-
qter in der(22) syndrome. However, genes in this region
of chromosome 11 may also counteract some of the
effect of the 22q11 duplication, since colobomata, mi-
crophthalmia, and TAPVR are common features of CES,
yet are rarely seen in the der(22) syndrome.
Perspectives
In the past few years, there has been much progress
toward understanding the molecular basis of chromo-
somal rearrangements that lead to genomic disorders.
Several other well-characterized genomic disorders are
associated with their own region-specific blocks of low-
copy repeats. These include Charcot-Marie-Tooth dis-
ease type 1A/hereditary neuropathy with pressure palsies
(CMT1A/HNPP), Smith-Magenis syndrome, Williams-
Beuren syndrome, and Prader-Willi syndrome/Angelman
syndrome, among others (reviewed in Lupski 1998;
Emanuel and Shaikh 2001). For CMT1A/HNPP, the re-
gion of chromosome breakage and strand exchange has
been narrowed to a single 557-bp hotspot within 27-kb
CMT1A repeats on 17p11-12. This interval lies near a
dysfunctional Mariner transposase sequence, and it has
been hypothesized that this might create a hotspot for
rearrangement (Reiter et al. 1996, 1998). For the other
genomic disorders, including VCFS/DGS and CES, the
precise sites of chromosome breakage and strand
exchange are not known. One essential question is
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whether similar hotspots exist within the larger 200-kb
LCR22s or whether they occur randomly in regions of
sequence similarity. The presence of hotspots would sug-
gest precise mechanisms for recombination events. Al-
terations in the sequence of these hotspots might alter
susceptibility to rearrangements, and this could be used
to predict the chances for occurrence of a particular
chromosomal rearrangement in an individual. Unlike
VCFS/DGS and CES, which are mediated by homolo-
gous recombination events between two LCRs, the re-
current constitutional t(11;22) translocation has been
defined to occur in AT-rich palindromes. Many nonre-
current translocations disrupt the 22q11 region. It is not
known whether these other translocations preferentially
occur in the same LCR, different LCRs, or unique se-
quences. This frequency will give us an indication of the
relative importance that this AT-rich sequence has in
human translocations. Of interest, a family with a
t(17;22) translocation that was associated with neuro-
fibromatosis type 1 had a disruption of the same region
on 22q11 as had a family with the t(11;22) translocation
(Kehrer-Sawatzki et al. 1997). As does 11q23, the in-
terval on chromosome 17 that is disrupted in the family
contains AT-rich palindromic sequence. This supports
the potential mutation mechanism discussed in previous
sections.
With respect to the molecular basis of rearrangement
disorders on 22q11, much progress has been made by
use of genetic approaches with mouse models. For
VCFS/DGS, a single candidate gene, TBX1, has been
implicated as causing the main clinical findings for the
disorder. However, proof that haploinsufficiency of this
gene is responsible for the syndrome in humans is lack-
ing, since mutations have not been identified in this gene
in nondeleted cases (Chieffo et al. 1997; Gong et al.
2001). Since the regulatory regions have not been de-
fined, the possibility of an inactivating mutation cannot
be excluded. However, one problem in these screens was
that none of the nondeleted cases were familial, which
makes a clear genetic basis for the phenotype question-
able in these cases. It is still surprising that not a single
patient has been identified who has a de novo inacti-
vating mutation in the coding region of this gene. This
suggests that, perhaps, in humans, haploinsufficiency of
additional genes may contribute to the etiology of the
disorder. Another important question is what the basis
for psychiatric disorders associated with VCFS/DGS is
and whether haploinsufficiency of TBX1, a gene not
expressed in the brain, could be responsible for its
etiology.
In contrast to VCFS/DGS, for which a clear candidate
gene has been identified through mouse-genetics ap-
proaches, efforts are still under way to identify candi-
date genes for CES and der(22) syndrome in mouse
mutants. Generating large duplications of the interval
and then rescuing mice by use of nested deletions, in
the opposite manner as forTbx1 and VCFS/DGS, would
be an obvious approach. Der(22) syndrome is partic-
ularly challenging because two different human chro-
mosomes are involved. Despite the challenges ahead,
we feel that the uncovering of the molecular basis of
these relatively rare human disorders can provide insight
into the molecular basis of mental retardation and con-
genital malformations.
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